T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$2.6B |
| 2 |
BNY
Bank of New York Mellon
BNY
|
+$1.1B |
| 3 |
Elevance Health
ELV
|
+$903M |
| 4 |
DD
Du Pont De Nemours E I
DD
|
+$873M |
| 5 |
Medtronic
MDT
|
+$868M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$3.89B |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$1.06B |
| 3 |
CFN
CAREFUSION CORPORATION
CFN
|
+$946M |
| 4 |
Aptiv
APTV
|
+$886M |
| 5 |
KSU
Kansas City Southern
KSU
|
+$662M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.05% |
| 2 | Consumer Discretionary | 13.82% |
| 3 | Financials | 13.14% |
| 4 | Industrials | 11.9% |
| 5 | Technology | 9.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
751
Chubb
CB
$133B
| $64M | 0.01% |
573,970
+17,590
| +3% | +$1.98M |
|
|
TUMI
752
DELISTED
TUMI HLDGS INC COM
TUMI
| $63.9M | 0.01% |
2,613,687
+22,529
| +0.9% | +$513K |
|
753
CF Industries
CF
$17.8B
| $63.7M | 0.01% |
1,122,490
+61,000
| +6% | +$3.64M |
|
754
Equinix
EQIX
$106B
| $63.5M | 0.01% |
272,559
+64,849
| +31% | +$14.7M |
|
755
RB Global
RBA
$16B
| $63.4M | 0.01% |
2,540,550
+16,860
| +0.7% | +$430K |
|
756
Silicon Laboratories
SLAB
$7.31B
| $62.8M | 0.01% |
1,236,730
-62,630
| -5% | -$3.04M |
|
|
FPO
757
DELISTED
First Potomac Realty Trust
FPO
| $62.5M | 0.01% |
5,257,447
-23,110
| -0.4% | -$284K |
|
|
TFM
758
DELISTED
THE FRESH MARKET, INC COM STK
TFM
| $62.4M | 0.01% |
1,536,527
-28,117
| -2% | -$1.1M |
|
759
Agios Pharmaceuticals
AGIO
$2.02B
| $62.3M | 0.01% |
660,232
+552,652
| +514% | +$61.9M |
|
|
SIAL
760
DELISTED
SIGMA - ALDRICH CORP
SIAL
| $62.1M | 0.01% |
449,422
-46,908
| -9% | -$6.47M |
|
|
SPLK
761
DELISTED
Splunk Inc
SPLK
| $62.1M | 0.01% |
1,048,547
+1,017,047
| +3,229% | +$61.5M |
|
762
Columbia Banking Systems
COLB
$9.2B
| $62M | 0.01% |
2,139,510
+220,810
| +12% | +$6.06M |
|
763
Travelers Companies
TRV
$77.6B
| $61.9M | 0.01% |
572,057
-13,450
| -2% | -$1.44M |
|
764
Banco Santander Chile
BSAC
$16B
| $61.7M | 0.01% |
2,847,042
-297,859
| -9% | -$6.03M |
|
765
HubSpot
HUBS
$10.7B
| $61.7M | 0.01% |
1,546,010
+1,237,110
| +400% | +$46.2M |
|
766
Chesapeake Utilities
CPK
$3.3B
| $61.6M | 0.01% |
1,217,995
+102,210
| +9% | +$5M |
|
|
PCH
767
DELISTED
PotlatchDeltic
PCH
| $61.5M | 0.01% |
1,536,050
-187,810
| -11% | -$7.6M |
|
768
Moody's
MCO
$83.6B
| $61.4M | 0.01% |
591,831
-6,900
| -1% | -$667K |
|
|
GG
769
DELISTED
Goldcorp Inc
GG
| $61.3M | 0.01% |
3,385,668
+970,212
| +40% | +$20.6M |
|
|
WMGI
770
DELISTED
Wright Medical Group Inc
WMGI
| $61.3M | 0.01% |
2,377,134
+694,723
| +41% | +$17.9M |
|
771
Fabrinet
FN
$21B
| $61.1M | 0.01% |
3,218,150
-180,890
| -5% | -$3.16M |
|
772
Valero Energy
VLO
$94.3B
| $60M | 0.01% |
943,034
+20,100
| +2% | +$1.12M |
|
773
Williams Companies
WMB
$89.6B
| $59.6M | 0.01% |
1,178,933
+36,630
| +3% | +$1.7M |
|
|
AWAY
774
DELISTED
HOMEAWAY INC COM
AWAY
| $59.6M | 0.01% |
1,975,520
-4,288,678
| -68% | -$124M |
|
775
UFP Industries
UFPI
$5.13B
| $59.4M | 0.01% |
3,209,310
-381,180
| -11% | -$6.63M |
|
Similar funds
T. Rowe Price Associates's Q1 2015 Portfolio in Review
As of Q1 2015, T. Rowe Price Associates held 2,630 positions worth $484B, up 2.8% from $471B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q1 2015 filing shows 93 new, 1,078 increased, 887 reduced and 93 closed positions. Its largest new stake was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M. The largest sale was Allergan Inc, an estimated $3.89B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q1 2015 buy was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M.
- T. Rowe Price Associates added most to Allergan plc in Q1 2015, an estimated $2.6B increase.
- T. Rowe Price Associates's biggest Q1 2015 reduction was Aptiv, cutting an estimated $886M.
- T. Rowe Price Associates fully exited Allergan Inc in Q1 2015, selling an estimated $3.89B.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $484B portfolio in Q1 2015.
- T. Rowe Price Associates opened 93 new positions and closed 93 in Q1 2015.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $484B.
Based on T. Rowe Price Associates's 13F filing for Q1 2015, filed 15 May 2015.